News About: Pharm. Industry
Large pharmaceutical firms eye M&As as growth engines
Large domestic pharmaceutical companies are eyeing mergers and acquisitions (M&As) with small- and medium-sized firms as part of efforts to find new growth engines in the rapidly changing business environment.
The ...
Dong-A Pharm targets W702 billion sales
Dong-A Pharmaceutical Co. has set this year's sales target of W702 billion won an increase of around 10 percent over the 600 billion won estimated for last year.
The company's operating profit has been set at 86 b...
Hanmi aims for W580 billion salesHanmi Pharm has set an ambitious goal of 580 billion won in sales this year.
The company's plan to boost sales this year was also reflected in last year's its slogan Speed Up...
|
Yungjin releases Naltrexone - treatment for alcoholism and addictionYungjin Pharm has launched its Naltrexin (naltrexone HCl), an opioid receptor antagonist used primarily in the management of alcohol dependence (alcoholism) and opioid addiction...
|
Successful strategy for merge and acquisition
Consolidation and convergence will likely be accelerating across the domestic pharmaceutical industry within a couple of years in the changing business environment of the 21st century, but Korean firms are still showi...
KAPW opposes GSK margin policy
The Korean Association of Pharmaceutical Wholesaler (KAPW) reaffirmed its official position to intensify its discord against GlaxoSmithKline's plan to reduce a wholesaler margin during its meeting with GSK's 20 associ...
KPTA officials to attend Informex USA 2008 Exhibition
The Korea Pharmaceutical Trade Association says its officials will attend Informex USA 2008 will be held at Morial Convention Center, New Orleans, USA between January 29 and February 1, 2008.
Informex USA is the wor...
KPMA to promote larger packets
The Korea Pharmaceutical Manufacturers Association said it will push ahead with a plan to change the mandatory smaller pack size from 30 tablets to 100 tablets.
Earlier, the KPMA demanded that the government acknow...
GSK's wholesaler margin policy under fire
A local group of drug wholesalers criticized the recent reduction of wholesaler margin by GlaxoSmithKline (GSK), calling for the company's perspective posture to boost a win-win strategy.
The Pharmaceutical Contrib...
Park He-yeon named Asia-Pacific medical directorJanssen Korea has promoted manager Park He-yeon, 50, to the post of medical director in Asia-Pacific region.
Park will be responsible for all GCP (good clinical practice) rel...
|
